• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  Oraxol
Date Designated:  04/16/2018
Orphan Designation:  Treatment of angiosarcoma
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Athenex, Inc. dba Kinex Pharmaceuticals, Inc.
1001 Main Street
Suite 600
Buffalo, New York 14203
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-